Healthcare Sector

Members of Parliament invested in the Healthcare Sector

154 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£138.04	219.24%	£223,468.99
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£138.04	199.24%	£209,468.88
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£12,546.00	4.34%	£73,038.92
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£12,546.00	204.81%	£213,367.35
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£12,546.00	223.64%	£226,549.72
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£12,546.00	69.04%	£118,326.60
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£12,546.00	6.56%	£74,589.77
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£12,546.00	370.50%	£329,353.08
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£12,546.00	3.21%	£72,245.80
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£12,546.00	131.60%	£162,122.95
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£12,546.00	5.22%	£73,651.46
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£12,546.00	22.64%	£85,847.51
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£12,546.00	56.73%	£109,708.93
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£12,546.00	327.03%	£298,917.63
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£1.83	-44.71%	£38,700.91
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£46.94	25.54%	£87,879.11
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£46.94	-12.15%	£61,497.28
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£46.94	9.72%	£76,806.92
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£46.94	19.20%	£83,438.29
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£46.94	10.94%	£77,660.12
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£46.94	18.87%	£83,205.87
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£46.94	4.89%	£73,425.70
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£46.94	6.63%	£74,643.34
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£46.94	25.61%	£87,926.14
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£189.05	14.55%	£80,188.45
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£189.05	54.15%	£107,905.25
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£189.05	160.08%	£182,053.93
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£189.05	210.27%	£217,191.86
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£189.05	16.90%	£81,829.71
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£215.05	198.04%	£208,629.41
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£215.05	-13.59%	£60,484.25
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£318.10	152.26%	£176,582.08
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£344.75	36.15%	£95,302.50
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£344.75	-29.65%	£49,243.97
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£344.75	-35.90%	£44,870.12
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£344.75	-33.47%	£46,569.86
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£344.75	-42.00%	£40,599.76
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£344.75	-4.54%	£66,821.27
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,377.01	104.76%	£143,334.03
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£556.22	33.02%	£93,115.69
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£556.22	21.12%	£84,782.25
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£556.22	-4.70%	£66,711.32
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£556.22	20.12%	£84,086.47
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£556.22	16.51%	£81,555.47
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£136.50	-77.72%	£15,597.45
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£136.50	-57.34%	£29,859.38
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£50.04	37.66%	£96,363.14
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£50.04	-50.79%	£34,445.86
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£50.04	-59.23%	£28,536.05
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£50.04	-62.84%	£26,012.18
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£144.10	-14.28%	£60,005.95
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£144.10	-11.50%	£61,951.85
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£122.61	38.73%	£97,111.34
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£122.61	85.64%	£129,945.64
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£122.61	126.88%	£158,817.66
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£236.50	3.96%	£72,769.23
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£261.70	3.91%	£72,737.74
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£261.70	-15.49%	£59,160.35
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£261.70	2.31%	£71,614.55
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£261.70	-13.63%	£60,458.75
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£124.67	393.42%	£345,397.27
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£124.67	14.57%	£80,195.73
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£124.67	278.94%	£265,255.30
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£16.43	-83.76%	£11,364.63
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£24.29	24.28%	£86,995.94
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£24.29	-16.31%	£58,585.04
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£35.77	58.24%	£110,767.32
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£35.77	70.49%	£119,344.77
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£342.90	293.73%	£275,611.44
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£368.98	431.52%	£372,062.83
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£368.98	34.17%	£93,922.18
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£41.25	-13.70%	£60,407.95
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£41.25	-24.93%	£52,547.77
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£6.57	-48.71%	£35,901.64
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£76.69	-3.46%	£67,576.79
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£76.69	45.63%	£101,942.65
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£26.87	-71.79%	£19,744.91
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£138.43	-49.43%	£35,397.62
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£228.20	41.91%	£99,334.62
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£530.02	90.76%	£133,530.32
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£530.02	51.09%	£105,765.27
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£530.02	-3.86%	£67,298.03
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£5.78	66.09%	£116,264.37
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.00	-100.00%	£0.33
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£466.80	1,404.84%	£1,053,384.89
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£26.05	4.16%	£72,910.25
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,485.00	-7.21%	£64,955.19
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£628.54	1,997.93%	£1,468,551.40
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£844.50	15.47%	£80,832.18
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,823.00	-10.02%	£62,986.18
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£2.68	-93.81%	£4,333.56
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£732.20	31.45%	£92,017.95
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£5.58	298.57%	£279,000.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£4.06	-43.06%	£39,859.75
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£2.57	33.85%	£93,697.91
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£1.46	40.38%	£98,269.23
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£34.02	126.05%	£158,232.56
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.05	-96.54%	£2,419.05
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.72	-94.04%	£4,172.00
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£7.34	-30.89%	£48,380.42
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£6.25	-44.44%	£38,888.89
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£36.94	22.81%	£85,964.09
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£28.14	-74.87%	£17,590.64
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£350.80	4.37%	£73,061.58
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£11.30	-10.67%	£62,529.65
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£319.50	53.98%	£107,783.13
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£319.50	16.95%	£81,863.10
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.70	-97.31%	£1,884.62
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£68.00	-39.29%	£42,500.00
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£68.00	32.04%	£92,427.18
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£87.50	400.86%	£350,601.05
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£4.63	-84.57%	£10,803.33
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.01	-23.80%	£53,341.77

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.